Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Department of Gastroenterology, Cangxi People's Hospital, Guangyuan, Sichuan, China.
Gastrointest Endosc. 2023 Apr;97(4):664-672.e4. doi: 10.1016/j.gie.2022.12.003. Epub 2022 Dec 9.
Although narrow-band imaging (NBI) is a useful modality for detecting and delineating esophageal squamous cell carcinoma (ESCC), there is a risk of incorrectly determining the margins of some lesions even with NBI. This study aimed to develop an artificial intelligence (AI) system for detecting superficial ESCC and precancerous lesions and delineating the extent of lesions under NBI.
Nonmagnified NBI images from 4 hospitals were collected and annotated. Internal and external image test datasets were used to evaluate the detection and delineation performance of the system. The delineation performance of the system was compared with that of endoscopists. Furthermore, the system was directly integrated into the endoscopy equipment, and its real-time diagnostic capability was prospectively estimated.
The system was trained and tested using 10,047 still images and 140 videos from 1112 patients and 1183 lesions. In the image testing, the accuracy of the system in detecting lesions in internal and external tests was 92.4% and 89.9%, respectively. The accuracy of the system in delineating extents in internal and external tests was 88.9% and 87.0%, respectively. The delineation performance of the system was superior to that of junior endoscopists and similar to that of senior endoscopists. In the prospective clinical evaluation, the system exhibited satisfactory performance, with an accuracy of 91.4% in detecting lesions and an accuracy of 85.9% in delineating extents.
The proposed AI system could accurately detect superficial ESCC and precancerous lesions and delineate the extent of lesions under NBI.
尽管窄带成像(NBI)是一种用于检测和描绘食管鳞状细胞癌(ESCC)的有用工具,但即使使用 NBI,也存在一些病变的边缘确定不准确的风险。本研究旨在开发一种人工智能(AI)系统,用于检测浅层 ESCC 和癌前病变,并描绘 NBI 下病变的范围。
从 4 家医院收集并注释非放大 NBI 图像。使用内部和外部图像测试数据集评估系统的检测和描绘性能。将系统的描绘性能与内镜医师进行比较。此外,该系统直接集成到内镜设备中,前瞻性评估其实时诊断能力。
该系统使用来自 1112 名患者和 1183 个病变的 10047 张静态图像和 140 个视频进行了训练和测试。在图像测试中,系统在内部和外部测试中检测病变的准确率分别为 92.4%和 89.9%。系统在内部和外部测试中描绘病变范围的准确率分别为 88.9%和 87.0%。系统的描绘性能优于初级内镜医师,与高级内镜医师相似。在前瞻性临床评估中,该系统表现出令人满意的性能,检测病变的准确率为 91.4%,描绘病变范围的准确率为 85.9%。
所提出的 AI 系统可以准确地检测浅层 ESCC 和癌前病变,并描绘 NBI 下病变的范围。